Gram Research analysis of a 2026 international study of 1,074 IBS patients found that bloating affects quality of life significantly more than abdominal pain, particularly among European patients. European IBS patients reported 2.1 times higher bloating severity than Asian/Australian patients, and bloating showed a correlation of -0.552 with reduced quality of life compared to pain’s correlation of -0.260. The study reveals that IBS symptoms and their impact vary substantially by region, suggesting treatment should be tailored to specific symptom patterns rather than using a one-size-fits-all approach.

A large international study of over 1,000 people with irritable bowel syndrome (IBS) found surprising differences between Asian/Australian and European patients. While both groups experience stomach pain, Europeans reported much more bloating and psychological stress from their symptoms. Interestingly, bloating affected quality of life more than pain did. The research also showed that Asian/Australian patients were more likely to have diarrhea-dominant IBS, while Europeans had more mixed symptoms. These findings suggest that IBS management should be tailored to each region’s specific symptom patterns and cultural factors.

Key Statistics

A 2026 cross-sectional study of 1,074 adults from the AEGIS survey found that bloating severity was significantly higher in European IBS patients compared to Asian/Australian patients, and bloating showed a substantially stronger association with impaired quality of life than abdominal pain.

Among 339 IBS patients in the 2026 AEGIS study, diarrhea-dominant IBS (IBS-D) predominated in Asia/Australia at 57.1% of cases, whereas mixed-type IBS (IBS-M) was more common in Europe at 31.6% of cases, demonstrating regional differences in IBS phenotype.

In the 2026 AEGIS survey of 1,074 participants, the proportion of IBS patients was significantly lower in Asia/Australia (20.9%) than in Europe (40.9%), suggesting substantial geographic variability in IBS prevalence or diagnosis patterns.

A 2026 analysis of 339 IBS patients across 11 international centers found that in Asian/Australian populations, postprandial symptoms were strongly associated with consumption of dairy products, gluten-containing foods, coffee, and carbonated beverages, indicating region-specific dietary triggers.

The Quick Take

  • What they studied: How IBS symptoms and their impact on daily life differ between people in Asia/Australia compared to Europe
  • Who participated: 1,074 adults from 11 medical centers across Asia, Australia, and Europe who were diagnosed with IBS using standard medical criteria
  • Key finding: European IBS patients experience significantly more bloating than Asian/Australian patients, and bloating affects their quality of life more than abdominal pain does
  • What it means for you: If you have IBS, your symptom pattern and what bothers you most may depend on where you live. Doctors should focus treatment on your specific symptoms rather than assuming all IBS patients need the same approach. This is especially important for bloating, which may need targeted strategies.

The Research Details

Researchers collected information from 1,074 people with IBS across 11 medical centers in Asia, Australia, and Europe. They asked participants to complete questionnaires about their IBS symptoms, how severe the symptoms were, how much the symptoms affected their daily life, their mood and stress levels, and which foods triggered their symptoms. The researchers then compared the answers between the Asian/Australian group and the European group to see if there were meaningful differences.

This type of study, called a cross-sectional study, takes a snapshot of a group of people at one point in time rather than following them over months or years. It’s useful for finding patterns and differences between groups, but it cannot prove that one thing causes another.

The study used validated questionnaires, meaning these are standardized tools that doctors and researchers have tested and confirmed work well for measuring IBS symptoms and quality of life. This makes the results more reliable than if researchers had simply asked people general questions.

Understanding regional differences in IBS is important because it helps doctors provide better, more personalized care. If European patients struggle more with bloating while Asian/Australian patients have different dominant symptoms, treatment strategies should reflect these differences. This research also highlights that bloating may be underestimated in IBS treatment, since it affected quality of life more than pain in this study.

This study included a large number of participants (1,074) across multiple countries, which strengthens the findings. The researchers used standardized diagnostic criteria (Rome IV) to identify IBS patients, ensuring consistency. However, the study is observational, meaning it shows associations but cannot prove cause and effect. The study also relied on self-reported symptoms, which can be influenced by cultural differences in how people describe their symptoms. Additionally, the study captured only one moment in time, so it cannot show how symptoms change over time.

What the Results Show

Among the 1,074 participants, 339 were diagnosed with IBS. Notably, IBS was less common in Asia/Australia (20.9% of participants) compared to Europe (40.9%), suggesting regional differences in either disease prevalence or diagnosis patterns.

The types of IBS also differed by region. In Asia/Australia, diarrhea-dominant IBS (IBS-D) was most common, affecting 57.1% of IBS patients. In Europe, mixed-type IBS (IBS-M), where symptoms alternate between diarrhea and constipation, was more common at 31.6% of patients. This means Asian/Australian patients more often struggle with loose stools, while European patients experience more variable bowel patterns.

European patients reported significantly higher bloating severity compared to Asian/Australian patients. Importantly, bloating showed a much stronger connection to reduced quality of life (correlation of -0.552) than abdominal pain did (correlation of -0.260). This means bloating was a bigger factor in how much IBS interfered with daily activities like work, social life, and sleep.

European patients also reported higher psychological burden, including more anxiety and stress related to their IBS, even though the intensity of abdominal pain was similar between regions. This suggests that factors beyond physical pain, particularly bloating and psychological stress, drive the overall disease burden in Europe.

Postprandial symptoms, meaning symptoms that occur after eating, were more common in European patients. However, in Asia/Australian patients, these after-meal symptoms were strongly linked to consuming specific foods: dairy products, gluten-containing foods, coffee, and carbonated beverages. This suggests that dietary triggers may play a more prominent role in Asian/Australian IBS, and that avoiding these foods might help reduce symptoms in that population.

Previous research has shown that IBS symptoms vary worldwide, but this study provides clearer evidence about which specific symptoms differ by region. Earlier studies focused mainly on abdominal pain, but this research highlights that bloating deserves equal or greater attention, especially in European populations. The finding that bloating affects quality of life more than pain contradicts the traditional focus on pain management in IBS treatment guidelines.

The study is observational, so it shows associations but cannot prove that region causes these symptom differences. Cultural differences in how people describe and report symptoms could influence results. The study captured only one moment in time, so it cannot show whether these patterns stay consistent or change over time. Additionally, the study did not explore why these regional differences exist, such as differences in diet, healthcare systems, or genetic factors. The study also relied on self-reported symptoms, which can be influenced by individual perception and cultural attitudes toward illness.

The Bottom Line

If you have IBS and live in Europe, ask your doctor about strategies to manage bloating specifically, as this appears to be a major factor affecting quality of life. If you live in Asia or Australia, focus on identifying dietary triggers, particularly dairy, gluten, coffee, and carbonated drinks, as these showed strong associations with symptoms. All IBS patients should work with their healthcare provider to develop a personalized treatment plan based on their specific symptom pattern rather than assuming all IBS is the same. These recommendations are based on observational evidence, so individual responses may vary.

People diagnosed with IBS in any region should care about this research, as it validates that their specific symptom pattern is real and recognized. Healthcare providers treating IBS patients should consider regional and cultural factors when recommending treatment. Researchers developing new IBS treatments should account for regional differences in symptom presentation. People without IBS may find this interesting for understanding how the same condition can look different in different parts of the world.

Changes in IBS symptoms typically take 2 to 4 weeks to become noticeable after starting a new dietary approach or treatment. However, some people may see improvements in bloating within days of avoiding trigger foods. Long-term management usually requires ongoing attention to diet, stress, and symptom patterns over months to find what works best for your individual situation.

Frequently Asked Questions

Why do people in Europe have more bloating from IBS than people in Asia?

The 2026 AEGIS study found European IBS patients reported significantly higher bloating severity, but the research did not determine why. Possible factors include dietary differences, genetic variation, healthcare practices, or how different cultures report symptoms. More research is needed to understand the underlying causes.

Is bloating or pain more important to treat in IBS?

According to the 2026 AEGIS study of 339 IBS patients, bloating showed a stronger association with reduced quality of life than pain did. This suggests bloating deserves equal or greater attention in IBS treatment, especially for European patients, though both symptoms should be addressed.

What foods trigger IBS symptoms in Asian and Australian patients?

The 2026 AEGIS study found that in Asian/Australian IBS patients, postprandial symptoms were most strongly linked to dairy products, gluten-containing foods, coffee, and carbonated beverages. Avoiding these foods may help reduce symptoms in this population.

Does IBS affect quality of life differently in different countries?

Yes. The 2026 AEGIS survey of 1,074 participants found European IBS patients reported higher psychological burden and greater overall symptom severity despite comparable abdominal pain intensity, suggesting regional differences in how IBS affects daily life and mental health.

What type of IBS is most common in Asia and Europe?

The 2026 AEGIS study found diarrhea-dominant IBS (IBS-D) predominated in Asia/Australia at 57.1%, while mixed-type IBS (IBS-M) was more common in Europe at 31.6%, showing distinct regional patterns in IBS subtypes.

Want to Apply This Research?

  • Track bloating severity daily on a scale of 0 to 10, along with abdominal pain, bowel movement type, and foods consumed. Record this data for at least 2 weeks to identify patterns specific to your region and dietary triggers.
  • If you live in Europe, prioritize bloating reduction strategies such as eating slowly, chewing thoroughly, and identifying gas-producing foods. If you live in Asia or Australia, use the app to log consumption of dairy, gluten, coffee, and carbonated beverages alongside symptom timing to identify which foods trigger your symptoms most.
  • Use the app to create a personalized symptom profile over 4 to 8 weeks. Compare your bloating and pain patterns to identify which symptom bothers you most. Adjust your dietary and lifestyle strategies based on what the data shows, and reassess every 4 weeks to track improvement.

This research is observational and shows associations between region and IBS symptoms, but cannot prove that region causes these differences. Individual IBS experiences vary widely. This information is for educational purposes and should not replace professional medical advice. If you have IBS or suspect you do, consult with a healthcare provider for proper diagnosis and personalized treatment recommendations. Do not make significant dietary changes without discussing them with your doctor or a registered dietitian, especially if you have other health conditions or take medications.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Global IBS, Local Patterns: Regional Variability in Pain, Bloating, and Impact on Daily Life Among Asian/Australian and European Patients From the Aegis Epidemiology Survey. , Neurogastroenterology and motility (2026). PubMed 42861429 | DOI
Topics
IBS bloating irritable bowel syndrome regional differences IBS Europe Asia bloating quality of life IBS symptoms by region postprandial IBS symptoms IBS dietary triggers AEGIS survey IBS